Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2961 (LINC02961) is a human gene encoding a long non-coding RNA (lncRNA), classified as an intergenic non-protein coding RNA[1][3][5][7][9]. LINC02961 does not encode a protein and instead belongs to the family of long intergenic non-coding RNAs, molecules increasingly recognized as key regulators of gene expression at the transcriptional and epigenetic levels[10]. There is currently no evidence establishing LINC02961 as a direct therapeutic target, nor is there detailed functional annotation available for this particular lncRNA. However, lncRNAs as a class are of growing interest in oncology and developmental biology due to their roles in gene regulation, chromatin remodeling, and potentially in cancer progression[10]. LINC02961 is also known by the alias PP2672[1][5][9].
None known
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on long intergenic non-protein coding RNA 2961 (LINC02961).